1. Industry
Send to a Friend via Email

Your suggestion is on its way!

An email with a link to:

http://pharma.about.com/b/2011/06/08/dr-reddys-soon-to-be-a-household-name.htm

was emailed to:

Thanks for sharing About.com with others!

Kathlyn Stone

Dr. Reddy’s Soon To Be A Household Name?

By June 8, 2011

Follow me on:

Dr. Reddy's facility in Bollaram, Hyderabad, India
Dr. Reddy's Active Pharmaceutical Ingredients Unit, Hyderabad, India. Photos courtesy Dr. Reddy's Laboratories

There really is a Dr. Reddy who heads up one of India's largest pharmaceutical companies that carries his name. While the familiar names in drug manufacturing are drifting overseas for business, Dr. Reddy's Labs is exceeding growth predictions primarily from expanding U.S. sales. In fact, the U.S. represented 34 percent of Dr. Reddy's generic drug sales worldwide, well ahead of its sales in its other major markets including India (21 percent), Europe (20 percent), and Russia (15 percent), according to the company's most recent annual report.

After it launched its authorized generic version of sumatriptan (a migraine drug marketed as Imitrix) in the United States in 2009, Dr. Reddy's overall revenue grew 9 percent to reach $1.56 billion in early 2010. The company expects to exceed $2.7 billion in sales by 2013.

The company announced June 6 that it has launched three more new generics in the United States: venlafaxine hydrochloride extended release caps, a generic version of Pfizer's Effexor XR, a depression and anxiety treatment; donepezil hydrochloride, the generic version of Pfizer and Eisai's Alzheimer's disease drug, Aricept, both of which gained Food and Drug Administration approval in May; and letrozole, a generic version of Femara, a breast cancer treatment for postmenopausal women developed by Novrtis. Dr. Reddy's letrozole was approved by the FDA on June 3.

Dr. Reddy's filed 12 new Abbreviated New Drug Applications (ANDAs) in the U.S and one in Canada during 2009 and 2010. The company currently has 74 ANDAs awaiting FDA approval.

And who is Dr. Reddy? That would be company founder and chairman, Dr. Kallam Anji Reddy.

Dr. Anji Reddy

Comments

March 21, 2012 at 8:11 am
(1) Judy S. says:

I had never heard of Dr. Reddys until I started getting one of my prescriptions through Express Scripts. Then I noticed the manufacturers name was “Dr. Reddys.” I investigated further to find out that they were located in India. I began to wonder how safe it were to take medicines made in India and how were these companies regulated. If anyone has any information on this, please let me know.

October 23, 2012 at 7:30 am
(2) Jay says:

It is a very respected Pharma company from India ranked No.1 or No.2. As far as regulations, US allows import from USFDA approved plants only. So, if the products landed successfully in the US, you can be sure about the quality. Dr.Reddys is nearly a USD 2 Bn company. Get well soon.

October 4, 2013 at 1:59 pm
(3) Alta M Bardsley says:

I also am concerned about drugs being made in India. I just received my first, a generic version of Singulair.
Is it safe? How many more generics will Express Scripts get from India and other countries.
I am not being a snob, but it is known that too often products made in foreign companies (other than Europe) are toxic or contain toxic materials. How are we to trust Dr. Reddy’s to have its consumers’ safety foremost in mind? Yes, they will say they are safe, but are they?
I am strongly considering seeking a different Prescription plan that is not serviced by Express Scripts!!!

Leave a Comment


Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>
Top Related Searches
  • household name
  • dr reddy
  • ©2014 About.com. All rights reserved.